BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34371178)

  • 21. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic
    Matsumoto T; Fujita M; Hirano R; Uchino J; Tajiri Y; Fukuyama S; Morimoto Y; Watanabe K
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2321-2327. PubMed ID: 27703342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model.
    Rosa CP; Pereira JA; Cristina de Melo Santos N; Brancaglion GA; Silva EN; Tagliati CA; Novaes RD; Corsetti PP; de Almeida LA
    J Leukoc Biol; 2020 Jan; 107(1):95-104. PubMed ID: 31682032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of
    Bielen K; 's Jongers B; Boddaert J; Raju TK; Lammens C; Malhotra-Kumar S; Jorens PG; Goossens H; Kumar-Singh S
    Front Cell Infect Microbiol; 2017; 7():274. PubMed ID: 28680858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
    Faure E; Mear JB; Faure K; Normand S; Couturier-Maillard A; Grandjean T; Balloy V; Ryffel B; Dessein R; Chignard M; Uyttenhove C; Guery B; Gosset P; Chamaillard M; Kipnis E
    Am J Respir Crit Care Med; 2014 Apr; 189(7):799-811. PubMed ID: 24555512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17 Aggravates
    Ding F; Han L; Fu Q; Fan X; Tang R; Lv C; Xue Y; Tian X; Zhang M
    Front Immunol; 2021; 12():811803. PubMed ID: 35095906
    [No Abstract]   [Full Text] [Related]  

  • 27. An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia.
    Hajjar AM; Harowicz H; Liggitt HD; Fink PJ; Wilson CB; Skerrett SJ
    Am J Respir Cell Mol Biol; 2005 Nov; 33(5):470-5. PubMed ID: 16100080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production.
    Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S
    Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.
    Buret A; Dunkley ML; Pang G; Clancy RL; Cripps AW
    Infect Immun; 1994 Dec; 62(12):5335-43. PubMed ID: 7960112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.
    Kamei A; Gao G; Neale G; Loh LN; Vogel P; Thomas PG; Tuomanen EI; Murray PJ
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6153-E6161. PubMed ID: 27671632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
    Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
    Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
    Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
    PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
    Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa.
    Tolle L; Yu FS; Kovach MA; Ballinger MN; Newstead MW; Zeng X; Nunez G; Standiford TJ
    J Innate Immun; 2015; 7(2):177-86. PubMed ID: 25402425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment.
    Wilkinson TS; Dhaliwal K; Hamilton TW; Lipka AF; Farrell L; Davidson DJ; Duffin R; Morris AC; Haslett C; Govan JR; Gregory CD; Sallenave JM; Simpson AJ
    Am J Pathol; 2009 Apr; 174(4):1338-46. PubMed ID: 19264904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
    Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
    Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-27 controls sepsis-induced impairment of lung antibacterial host defence.
    Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y
    Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.
    Chroneos ZC; Wert SE; Livingston JL; Hassett DJ; Whitsett JA
    J Immunol; 2000 Oct; 165(7):3941-50. PubMed ID: 11034402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection.
    Jiang D; Matsuda J; Berman R; Schaefer N; Stevenson C; Gross J; Zhang B; Sanchez A; Li L; Chu HW
    Innate Immun; 2017 Feb; 23(2):206-215. PubMed ID: 28120642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice.
    Sapru K; Stotland PK; Stevenson MM
    Clin Exp Immunol; 1999 Jan; 115(1):103-9. PubMed ID: 9933427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.